Cao Hai-Xia, Li Su-Ping, Wu Jian-Zhong, Gao Chang-Ming, Su Ping, Liu Yan-Ting, Zhou Jian-Nong, Ding Jian-Hua
Division of Epidemiology, Jiangsu Provincial Institute of Cancer Research, Jiangsu Province, China.
Asian Pac J Cancer Prev. 2010;11(4):1073-7.
To investigate the relationship among alcohol dehydrogenase-2 (ADH2) and aldehyde dehydrogenase-2 (ALDH2) genetic polymorphisms, alcohol consumption, and the susceptibility of stomach cancer in Chinese males.
Three hundred and eighty-two stomach cancer patients and 382 healthy controls from Taixing and Changshu city of Jiangsu province were enrolled in this study. ADH2 and ALDH2 genotypes were examined by PCR and denaturing high-performance liquid chromatography (DHPLC). Unconditional logistic regression was used to calculate the odds ratios (OR) and 95% confidence intervals (95% CI).
(1) In no drinkers, compared with ALDH2G/G carriers, ALDH2 G/A (OR=1.67, 95%CI: 1.01-2.78) carriers showed a significantly elevated risk of developing stomach cancer. No association was found between ADH2 genotypes and risk of stomach cancer. (2) ALDH2 A allele carriers with cumulative amount of alcohol consumption≥2.5 (Kgyears) were at a higher risk of developing stomach cancer compared with those with cumulative amount of alcohol consumption<2.5 Kg (Kgyears) (OR=2.72, 95%CI:0.89-8.31) and ALDH2 G/G carriers with cumulative amount of alcohol consumption<2.5 (Kgyears) (OR=2.46, 95%CI=0.90-6.72) or≥2.5 (Kg * years) (OR=2.53, 95%CI=0.86-7.49). (3) Compared with individuals with ADH2 A/A and ALDH2 G/G genotypes, ADH2 G and ALDH2 A allele carriers were not at a high risk of developing stomach cancer, with regard to the status of alcohol consumption, and even cumulative amount of alcohol consumption≥1.5 (Kgyears) (OR=1.65, 95%CI:0.56-4.82).
ADH2 and ALDH2 polymorphisms and alcohol drinking may not play an important role in the development of stomach cancer in Chinese males.
探讨乙醇脱氢酶2(ADH2)和乙醛脱氢酶2(ALDH2)基因多态性、饮酒量与中国男性胃癌易感性之间的关系。
本研究纳入了来自江苏省泰兴市和常熟市的382例胃癌患者和382例健康对照。采用聚合酶链反应(PCR)和变性高效液相色谱法(DHPLC)检测ADH2和ALDH2基因型。采用非条件logistic回归计算比值比(OR)和95%置信区间(95%CI)。
(1)在不饮酒者中,与ALDH2 G/G携带者相比,ALDH2 G/A携带者(OR=1.67,95%CI:1.01-2.78)患胃癌的风险显著升高。未发现ADH2基因型与胃癌风险之间存在关联。(2)与累计饮酒量<2.5(Kg年)的ALDH2 G/G携带者(OR=2.46,95%CI=0.90-6.72)或≥2.5(Kg年)的ALDH2 G/G携带者(OR=2.53,95%CI=0.86-7.49)相比,累计饮酒量≥2.5(Kg年)的ALDH2 A等位基因携带者患胃癌的风险更高。(3)就饮酒状况而言,与ADH2 A/A和ALDH2 G/G基因型个体相比,ADH2 G和ALDH2 A等位基因携带者患胃癌的风险并不高,即使累计饮酒量≥1.5(Kg年)(OR=1.65,95%CI:0.56-4.82)。
ADH2和ALDH2基因多态性及饮酒在中国男性胃癌发生过程中可能不起重要作用。